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Satellite cells are recognized as the main source for myoblasts in postnatal muscle. The possible participation of other cell types in myofiber
maintenance remains a subject of debate. Here, we investigated the potential of vascular preparations from mouse retina to undergo myogenesis
when cultured alone or with differentiated primary myogenic cultures. The choice of retina, an organ richly supplied with capillary network and
anatomically separated from skeletal muscles, ensures that the vasculature preparation is devoid of satellite cells. We demonstrate that retina-
derived cells spontaneously fuse with preexisting myotubes and contribute additional myonuclei, some of which initiate expression of muscle-
specific genes after fusion. Myogenic differentiation of retinal cells prior to their fusion with preexisting myotubes was not detected. Although
originating from vasculature preparations, nuclei undergoing myogenic reprogramming were contributed by cells that were neither endothelial nor
blood borne. Our results suggest smooth muscle/pericytes as the possible source, and that myogenic reprogramming depends on the muscle
specific transcription factor MyoD. Our studies provide insights into a novel avenue for myofiber maintenance, relying on nuclei of non-myogenic
origin that undergo fusion and subsequent myogenic conversion within host myofibers. This process may support ongoing myofiber maintenance
throughout life.
© 2007 Elsevier Inc. All rights reserved.Keywords: Retina; Vasculature; Endothelial cells; Pericytes; Skeletal muscle; Myogenesis; Satellite cells; Sca1; MyoD; Myf5Introduction
Skeletal muscle is composed of myofibers, multinucleated
syncytia, established during embryogenesis by fusion of
myoblasts. Myoblasts continue to fuse with the growing
myofibers during postnatal development until the myofibers
reach their mature size. Nuclei within myofibers are postmitotic
and normally do not contribute new myonuclei. Injury of adult
muscle results in reinitiation of myogenesis to provide
myoblasts that fuse with existing myofibers or form new
myofibers, depending on the degree of the damage.Myoblasts in
postnatal muscle are classically considered to be derived from
satellite cells, myogenic progenitors residing beneath the⁎ Corresponding author. Fax: +1 206 543 1524.
E-mail address: reuveni@u.washington.edu (Z. Yablonka-Reuveni).
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doi:10.1016/j.ydbio.2007.08.056myofiber basal lamina (Zammit et al., 2006). Satellite cells
contribute proliferating and differentiating myoblasts and also
can self-renew, thus, fulfilling the definition of tissue-specific
stem cells (Collins et al., 2005).
Satellite cells and their progeny are characterized by
temporal expression of transcription factors associated with
different stages of myogenic progression. Quiescent satellite
cells commonly express the paired-homeobox transcription
factor Pax7, while their proliferating progeny co-express Pax7
and the myogenic determination factor MyoD. The induction of
the muscle-specific transcription factor myogenin along with a
concomitant decline in Pax7, marks the transition of satellite
cell progeny into the differentiation phase and is followed by the
expression of muscle structural genes such as sarcomeric
myosin and fusion into myotubes (Halevy et al., 2004; Shefer
et al., 2006; Zammit et al., 2006). The muscle-regulatory gene
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proliferating progeny, and this activity declines following
formation of myotubes (Beauchamp et al., 2000; Day et al.,
2007; Zammit et al., 2006).
The view that satellite cells are the sole source of myogenic
progenitors in adult muscle has been challenged in recent years
by the identification of cells with a myogenic potential that are
residents of the bone marrow or associated with the vasculature
(Asakura et al., 2002; Dellavalle et al., 2007; Ferrari et al., 1998;
Gussoni et al., 1999; LaBarge and Blau, 2002; Peault et al.,
2007; Sampaolesi et al., 2006). Intramuscular cell populations
that express stem cell-associated antigens such as CD34 and
Stem Cell Antigen-1 (Sca1) are also demonstrated to posses
myogenic potential (Asakura et al., 2002; Deasy et al., 2007;
Gussoni et al., 1999; Torrente et al., 2001). The significance of
atypical myogenic progenitors contributed by the bone marrow
and the circulation, has remained controversial and not
uniformly demonstrated across different experimental models
(Dreyfus et al., 2004; LaBarge and Blau, 2002; Sherwood et al.,
2004). Nevertheless, the possibility that microvasculature can
produce myogenic cells has gathered continuous momentum,
starting with the report that the developing dorsal aorta contains
multipotential cells, namedmesoangioblasts, that can give rise to
a range of mesodermal cell types, including myogenic cells (De
Angelis et al., 1999; Minasi et al., 2002; Peault et al., 2007).
During postnatal development, similar cells with myogenic
potential were identified within the microvascular niche,
although their numbers drastically reduced with the maturation
of the organism (Cusella De Angelis et al., 2003). In addition,
cells displaying characteristics of skeletal muscle myoblasts
were identified in a range of fetal organs (Gerhart et al., 2001)
and in the thymus (Grounds et al., 1992). Vasculature is the
common component of all these tissues, and it is thus compelling
to propose that the atypical myogenic progenitors could either
originate from the circulation or be actual residents of the
vasculature wall.
The vasculature wall is comprised of a single layer of
endothelium surrounded by contractile cells. The latter have
been typically subdivided into smoothmuscle cells and pericytes
(also known asMural cells), based on the gradual transition from
the larger vessels to the microvasculature (Armulik et al., 2005;
Diaz-Flores et al., 1991). We previously demonstrated that
vascular-derived smooth muscle cell lines spontaneously
initiated MyoD expression and produced progeny that fused
into myotubes (Graves and Yablonka-Reuveni, 2000). However,
because these cells had been passaged for a long time in culture,
it was unclear if our findings were applicable to primary smooth
muscle cells. In the present study, we aimed to determine the
type of microvasculature-associated cells that indeed may
contribute to atypical myogenesis, and the involvement of
myogenic transcription factors in the process.
Skeletal muscle is especially rich in microvasculature, with
an extensive capillary network surrounding individual myofi-
bers (Day et al., 2007). However, isolation of vascular-
associated cells from muscle requires a variety of enrichment
protocols and the purified cells may still contain subpopulations
of residual satellite cells that express unanticipated antigens. Forexample, the expression of Sca1 has served as a means to enrich
for murine hematopoietic stem cells, but additional studies
demonstrated that Sca1 is also expressed by non-hematopoietic
progenitors and endothelial cells (Day et al., 2007; Holmes and
Stanford, 2007; van de Rijn et al., 1989). Moreover, rare Sca1-
expressing cells, identified in association with myofibers, may
in fact represent a subpopulation of activated satellite cells
(Mitchell et al., 2005). This is supported by the observation that
progeny of bona fide satellite cells do express Sca1 (Mitchell et
al., 2005; current study). Thus, Sca1+ cells isolated from
skeletal muscle and able to contribute to muscle regeneration
(Asakura et al., 2002; Gussoni et al., 1999; Torrente et al., 2001)
did not necessarily represent non-satellite progenitors. Earlier
studies also identified other endothelial cell markers that were
expressed by bona fide satellite cells (De Angelis et al., 1999).
CD34 is another example of a common stem cell antigen
expressed by satellite cells (Beauchamp et al., 2000), which was
originally used to identify other cell types in the muscle. In the
same vein, the so-called myoendothelial cells expressing both
myogenic markers and the endothelial marker CD31, detected
in human fetal muscle tissue (Cerletti et al., 2006), may
represent a transitory compartment of typical myoblasts.
To bypass possible contribution of bona fide satellite cells
to vascular cell preparations, the present study focused on
cells isolated from murine retina—an organ richly supplied
with capillary network and anatomically separated from
skeletal muscle. Preparations of enriched vascular cells from
the retina never displayed any characteristics of conventional
myogenic progenitors when cultured alone or with host
primary myogenic cultures. However, when cultured onto
primary myogenic cultures following the initial development
of myotubes, retina-derived cells spontaneously fused with
host myotubes and some of the contributed donor nuclei
expressed skeletal myogenic genes. These co-culture studies
provide novel insights into the process of myogenic
reprogramming and raise the possibility that in addition to
satellite cell contribution during muscle repair, myofiber
nuclei may be maintained by a non-canonical pathway that
involves direct fusion of non-myogenic cells, residents of the
muscle vasculature.
Materials and methods
Animals
Animal care and experimental procedures were approved by the Institutional
Animal Care and Use Committee at the University of Washington. Chickens
(White Leghorn, 8- to 9-day old) were kindly provided by Drs. O. Bermingham-
McDonogh and E. Rubel (University of Washington). Mice were from colonies
maintained at the University of Washington and were housed in micro-isolator
cages in a pathogen-free facility under 12-h light/dark cycle and were fed ad
libitum Lab Diet 5053 (Purina Mills). Unless otherwise mentioned, mice (males
and females) used to prepare primary myogenic cultures were 1.5–4 months old
and those used to prepare retinal cells were 1–2 months old. Wild type mice of
C57BL/6 background were used routinely except when the use of BALB/c mice
was specifically indicated. Additionally, the following genetically manipulated
mouse strains were used:
• eGFP transgenic, C57BL/6 (C57BL/6-Tg(ACTB-EGFP)1Osb/J; Jackson
Laboratory; Okabe et al., 1997); enhanced green fluorescence protein is
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enhancer in all tissues with the exception of erythrocytes and hair.
• MLC3F-nLacZ transgenic, C57BL/6 (Beauchamp et al., 2000; Kelly et al.,
1995); developed by Drs. R. Kelly and M. Buckingham (Pasteur Institute).
In these mice regulatory elements of muscle specific myosin light chain 3F
(MLC3F) drive LacZ expression in myofiber nuclei. Breeding pairs were
kindly provided by Dr. M. Goodell (Baylor College of Medicine).
• Myf5nLacZ/+ (Beauchamp et al., 2000; Tajbakhsh et al., 1996); developed by
Drs. S. Tajbakhsh and M. Buckingham (Pasteur Institute). In these mice,
LacZ was knocked into the Myf5 gene and its expression reports Myf5
promoter activity in nuclei of satellite cells. Breeding pairs on enriched
BALB/c background were kindly provided by Dr. M. Rudnicki (Ottawa
Health Research Institute). Mice used in the present study were either on
BALB/c background or crossed with C57BL/6 mice without any apparent
effect on the results.
• XLacZ4, C57BL/6 (Armulik et al., 2005; Klinghoffer et al., 2001; Tidhar et
al., 2001) were used to trace vascular smooth muscle/pericytes. In this
promoter trap mouse, it is unknown what elements drive LacZ expression.
Mice were developed in the laboratory of Dr. M. Shani (Volcani Center);
breeding pairs were kindly provided by Dr. P. Soriano (Fred Hutchinson
Cancer Research Center).
• Sca1-GFP, transgenic, C57BL/10×CBA (Ma et al., 2002; Mitchell et al.,
2005) have been used in our studies to trace endothelial cells (Day et al.,
2007). Mice were developed by Dr. E. Dzierzak (Erasmus University);
breeding pairs were kindly provided by Dr. G. Pavlath (Emory University).
• MyoD-GFP transgenic, homozygous, enriched FVB; GFP expression is
driven by the same MyoD regulatory elements described previously for the
generation of MyoD-LacZ transgenic mice in Dr. D. Goldhamer’s laboratory
(Chen et al., 2001). To maintain sufficient GFP signal for detection in live
cells in culture, only homozygous mice were used in the present study.
• MyoD−/−, enriched BALB/c (Rudnicki et al., 1992; Yablonka-Reuveni et al.,
1999); breeding pairs were kindly provided by Dr. M. Rudnicki.
Cell culture media, plates, and coating matrix
DMEM consisted of Dulbecco’s modified Eagle’s medium (high glucose,
with L-glutamine, 110 mg/l sodium pyruvate, and pyridoxine hydrochloride)
supplemented with antibiotics (50 U/ml penicillin and 50 mg/ml streptomycin);
all from GIBCO-Invitrogen. MEM consisted of Minimal essential medium
(GIBCO-Invitrogen) supplemented with 1% non-essential amino acids (Cellgro
by Mediatech) and antibiotics as in DMEM. Medium supporting endothelial
growth (Su et al., 2003) consisted of DMEM containing 20% fetal bovine serum
(FBS, Sigma), 20 mMHEPES, 1% non-essential amino acids, heparin (55 U/ml,
Sigma), and endothelial growth supplement (100 μg/ml, Sigma-Aldrich).
Medium for mouse myogenic cultures consisted of DMEM containing 20%
FBS, 10% horse serum (HS, HyClone), and 1% chicken embryo extract (Shefer
et al., 2006). Medium for chicken myogenic cultures consisted of MEM
containing 10% horse serum and 5% chicken embryo extract (Halevy et al.,
2004). All types of cultures (apart from those for fluorescence in situ
hybridization, detailed below) were maintained in standard 24-well Falcon
plates (BD Biosciences). Culture wells were coated with Matrigel (growth factor
reduced, BD Biosciences, diluted 1:10 in DMEM) as previously described
(Shefer et al., 2006).
Isolation and culturing microvascular cells from mouse retina
Retinal microvasculature preparations were obtained from enucleated mouse
eyes following previously described procedures (Gitlin and D’Amore, 1983; Su
et al., 2003) with some modifications. Eyes were placed in DMEM, fixed from
the side of the optic nerve using a fine-tipped forceps, and the cornea was
bisected with micro scissors and removed. The lens was then removed and the
retina was carefully pulled out with the forceps, separated from the ciliary body,
cleaned from the pieces of pigmented epithelium, and rinsed extensively with
DMEM to minimize any possible debris. Control studies (detailed in Results)
demonstrated that the preparation was free of any residual extraocular muscle
(EOM) fragments. Retinas from 2–4 mice were pooled together, cut into small
pieces, and subjected to enzymatic digestion for 2 h at 37 °C in a solution
containing collagenase-dispase (1 mg/ml, Roche) and DNase type I (0.5 mg/ml,Sigma) to release single cells. Enzymes were dissolved in DMEM containing
2% FBS; at this level, FBS did not inhibit enzyme activity, but increased
viability of cells during dissociation. The resulting suspension was gently
triturated with a 21 gauge needle to disengage cells from the digested tissue. The
suspension was filtered through a 40 μm nylon mesh (Falcon) to remove
undigested material. FBS was added to the suspension to the final concentration
of 10%. The filtered material was subjected to low speed centrifugation (800–
1000×g for 10 min). The final pellet was washed once with DMEM/10%FBS
and re-suspended in the medium for cell growth. Retinal cell preparations were
eventually dispensed into 24-well plates; each well received cell equivalence of
2 retinas in 0.5 ml medium. In experiments where retinal cells were seeded into
primary myogenic cultures, the final cell pellet was suspended in the complete
myogenic medium.
The aforementioned retinal digestion procedure minimized survival of
neuronal cells. Only about 1% of the total cells recovered by the isolation
procedure survived and adhered within the initial days in culture. The majority
of these cells appeared to be vascular cells as revealed by immunostaining
(more details in Results). The remaining 99% of the cells in the final digest,
which were of neuronal origin, were dead or damaged. They did not adhere to
the culture plate and were typically removed 2 days after culturing, upon the
first medium change.
In some studies, retinal cells from GFP-expressing mice were sorted by
FACS into GFP+ and GFP− populations. Digested retinal cells were re-
suspended in DMEM/2%FBS and subjected to FACS using an Influx Cell
Sorter (Cytopeia Incorporated) with UV (351–364 nm) and 488 nm argon
lasers as previously described (Day et al., 2007). Gating of GFP positive events
was set to at least 10 times the fluorescence intensity of negative events. Sorted
cells were collected directly into rich growth medium for primary myogenic
cultures, harvested by low speed centrifugation, and further analyzed in cell
culture. The percentage of GFP+ sorting events depended on the mouse model
and was below 1% of total events (specific details are provided in Results). The
percentage of GFP− sorting events was ∼30% and the remaining ∼70% events
accounted for debris that appeared to be contributed by dead retinal neurons.
Also, within the ∼30% GFP− population, the majority of cells did not adhere
to the culture plate and died during the initial two days in culture, appearing to
represent additional damaged neuronal cells.
Mouse and chicken myogenic cultures
Unless otherwise noted, mouse primary myogenic cultures were prepared
from the pooled hindlimb muscles tibialis anterior, extensor digitorum longus
(EDL), and gastrocnemius by digestion with 0.1% Pronase (Calbiochem) as
previously described (Shefer et al., 2006). Cells were cultured into 24-well plates
coated with Matrigel at a density of 2×104 per well using our standard growth
medium for mouse myogenic cultures detailed above. Single myofibers were
isolated from hindlimb EDL muscles of adult mice and cultured individually as
previously described (Shefer et al., 2006).When primarymyogenic cultureswere
prepared from extraocularmuscles, muscleswere harvested from enucleated eyes
and cultures were prepared as described for limb muscles. Chicken primary
myogenic cultures were prepared from breast muscle according to our previous
publication (Halevy et al., 2004) and cultured into Matrigel-coated wells, using
standard growth medium for chicken myogenic cultures.
Isolation and culture of bone marrow-derived and blood borne cells
Bone marrow was isolated from tibia bones as described previously
(Goodell et al., 1996) and single cell suspensions were obtained by trituration
with a 22 gauge needle. Blood was drawn from the retro-orbital plexus with a
heparinized capillary and depleted from erythrocyte via hypotonic shock with
distilled water (Terstappen et al., 1989). Cells were washed by low-speed
centrifugation and used for further analysis in co-cultures with primary
myoblasts.
Immunofluorescent staining
Cultures were fixed with paraformaldehyde, permeabilized with Triton-
X100 (permeabilization was omitted when labeling for Sca1), blocked with
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previously described (Shefer et al., 2006). Cultures were analyzed by single
or double immunofluorescence using mouse, rat, and rabbit primary antibodies
followed by species-specific Alexa Fluor 488 and 568 secondary antibodies
(Molecular Probes, 1:1000).
Primary antibodies were against the following antigens: · Pax7 (mouse
IgG1, ascites fluid, Developmental Studies Hybridoma Bank [DSHB], 1:2000
dilution); · MyoD (mouse IgG1, clone 5.8A, BD Biosciences, 1:800); ·
myogenin (mouse IgG1, clone F5D, hybridoma supernatant, DSHB, 1:2); ·
sarcomeric myosin heavy chain (mouse IgG2b, clone MF20, hybridoma
supernatant, DSHB, 1:2); · beta-galactosidase (β-gal) (mouse IgG2a, clone JIE7,
hybridoma supernatant, DSHB, 1:16); · GFP (rabbit, Novus Biologicals,
1:10,000); · Pax6 (mouse IgG1, hybridoma supernatant, DSHB, 1:2; provided
by T. Reh, University of Washington); · Sca1 (rat IgG, Pharmingen, 1:100;
provided by J. Chamberlain, University of Washington); · CD31 (rat IgG,
Pharmingen, 1:100); · Tie2 (mouse IgG1a, Pharmingen, 1:50). Biotinylated
isolectin-B4 (Vector Laboratories) was also used for endothelial cell identifica-
tion as previously detailed (Day et al., 2007).
Histochemical detection of β-galactosidase activity
β-gal activity was detected by X-Gal staining (Beauchamp et al., 2000)
omitting detergents from the staining solution. Cultures from LacZ-expressing
mice were fixed with 2% paraformaldehyde for 10 min, rinsed with PBS,
incubated in X-Gal solution for 2–16 h at 37 °C, and then rinsed in PBS. When
cultures were also analyzed for GFP expression, GFP detection was enhanced
with anti-GFP antibody since X-Gal staining often resulted in reduced GFP
fluorescence intensity.
Y-chromosome in situ detection
Y-chromosome FISH was performed as previously described (Gussoni et al.,
1999; Muskiewicz et al., 2005) to detect male retinal donor nuclei when co-
cultured with primary myogenic cells of female origin. Co-cultures were
generated in 8-well chamber glass slides Labtech II (Nalgene Nunc) precoated
with diluted Matrigel as described above. Positive and negative control
myogenic cultures from males and females, respectively, were grown and
processed in parallel with the co-cultures. Cultures were fixed in Histochoice
tissue fixative (Amresco) for 30 min, rinsed in PBS, dehydrated through graded
alcohols (50%, 70%, 90%, 100%, 5 min each), and stored at −20 °C.
Y-chromosome in situ hybridization was detected with sheep anti-digoxigenin-
rhodamine (Roche Applied Science; diluted 1:100) and slides were mounted
with Vectashield containing DAPI.
Microscope and imaging system
Y-chromosome FISH was analyzed with a Nikon Eclipse E1000 equipped
with a Hamamatsu Orca ER digital camera and images were acquired using
Openlab software (Improvision). In studies where β-gal+ cells were identified by
X-Gal reaction, images were acquired with Nikon Coolpix 4500 camera. All
other observations were made with an inverted fluorescent microscope (Nikon
Eclipse, TE2000-S). Images were acquired with a Qimaging Retiga 1300i Fast
1394 monochrome CCD camera. The CCD camera drive and color acquisition
were controlled byMetaView Imaging System (Universal Imaging Corporation).
Composites of digitized images were created using Adobe Photoshop software.Results
Cells present in retinal vasculature preparations can fuse with
myotubes
To isolate cells of the retinal vascular wall, we modified a
published collagenase digestion method (Gitlin and D’Amore,
1983; Su et al., 2003) and used a combination of collagenase,
dispase, and DNase (as described in Materials and methods).These enzymes are used to release microvascular cells from
the brain (Song and Pachter, 2003) and do not support survival
of mature neuronal cells of the retina (Shen et al., 1995). As
shown below, the dissociated retinas yielded cell cultures
comprised predominantly of endothelial and smooth muscle
cells.
These retinal vasculature preparations, referred to in the
present study as “retinal preparations” or “retinal cells”, were
investigated for their capacity to give rise to myogenic cells.
Retinal cells were first cultured alone in media supporting
endothelial or myogenic cell growth or in conditioned media
from primary myogenic cultures. Cell morphology and growth
characteristics varied under the different medium conditions,
but none of the cells in these cultures was confirmed to be
myogenic. This conclusion was based on immunostaining
analyses, demonstrating the absence of cells expressing
characteristic transcription factors of the myogenic lineage
(i.e., Pax7, MyoD, and myogenin) and the absence of mono- or
multi-nucleated cells expressing sarcomeric myosin, while
parallel control primary myogenic cultures contained positive
cells (data now shown).
We then asked if the retinal preparations can produce
myogenic cells upon their exposure to a myogenic niche. The
retinal cells were cultured onto primary myogenic cultures that
were isolated from hindlimb muscles of wild-type (C57BL/6)
mice and grown in Matrigel-coated 24-well plates. Each co-
culture was established in 3–5 parallel wells with retinal
preparations equivalent to 1–2 retinas per well. To distinguish
the retinal “donor” cells and the “host”myogenic cells in the co-
cultures, retinal preparations were isolated from eGFP mice.
Retinal cells were added to the myogenic cultures either before
myotubes were formed (semi-confluent culture, day 4) or
following the initial development of myotubes (confluent
culture, day 7). Co-cultures were then followed for an additional
7–12 days. In both cases, the co-cultures demonstrated
individual eGFP+ cells of various morphologies, some of
which showed clonal growth with time. The majority of these
eGFP+ cells displayed morphological characteristics of
endothelial cells and formed endothelial tubes, which expressed
CD31 (Figs. 1A–A″) and Tie2 (not shown), and displayed
endothelium-characteristic binding of isolectin-B4 (Day et al.,
2007). None of the mononuclear eGFP+ cells expressed
myogenic markers such as Pax7, MyoD, myogenin, or
sarcomeric myosin, while the “host” myogenic cells (i.e.,
eGFP− cells) in the same co-cultures expressed these proteins
(e.g., Figs. 1B′ and C′).
Myotubes expressing eGFP were also detected in the co-
cultures (Figs. 1B–C″), but such myotubes were found only
when the retinal cells were added to host cultures that begun
forming myotubes (i.e., when host myogenic cultures were 7-
day old, but not when host cultures were 4-day old and lacked
myotubes). Each co-culture displayed 1–2 eGFP+ myotubes
within the initial 1–2 days of co-culture. The number of eGFP+
myotubes gradually increased during the next several days,
culminating in 20–50 visible eGFP+ myotubes per well within
the 12 days of co-culturing. We report only on the absolute
numbers of eGFP+ myotubes per well arising from 1–2 retinas,
Fig. 1. Retinal cells from eGFP mouse co-cultured onto a day 7 primary myogenic culture with developing myotubes. Endothelial cells represent the predominant cell
type in retina-derived cells, as revealed by CD31 immunolabeling; endothelial tube networks develop after a week of co-culture (A–A″). Retinal cells fusing with
preexisting myotubes give rise to GFP+ myotubes, which are indistinguishable from the GFP-myotubes, based on immunostaining for sarcomeric myosin (B–B″) and
MyoD (C–C″). Micrographs of GFP+ cells are merged with parallel micrographs of immunostained cells (B″ and C″). Arrows point to endothelial tubes (A–A′) or
myotubes (B–B″ and C–C″) in parallel images. Scale bar, 50 μM.
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eGFP+ myotubes to total myotube number in the elaborate
myotube networks. eGFP+ myotubes were indistinguishable
from the rest of the myotubes present in the co-cultures with
regard to morphology, expression of muscle specific markers
such as sarcomeric myosin and MyoD (Figs. 1B–C″), and
ability to contract spontaneously (data not shown).
Notably, the finding that the addition of retinal cells to
myogenic cultures prior to formation of myotubes (i.e., whenFig. 2. FISH Y-chromosome analysis of retinal cells from male eGFP mouse in
representative fields are shown (A–C). Typically, 1–2 donor retinal nuclei (pointed to
out by the in situ hybridization reagents.host cultures were 4 days old) did not yield eGFP+ mono-
nucleated cells expressing myogenic traits indicated that the
retina-derived cells do not enter myogenic differentiation on
their own. Also, the addition of eGFP+ retinal cells when
myotubes were “older” (i.e., when host myogenic cultures were
9 to 12 days old) did not yield eGFP+ myotubes, as determined
by direct fluorescent analysis or with an antibody against GFP
(not shown). This observation indicates that fusion of retinal
cells with myotubes can take place only during a specific timehost myotubes from wild-type female mouse following co-culturing. Three
with arrows) were detected in eGFP+ myotubes. eGFP signal was often bleached-
Fig. 3. Transgenic MLC3F promoter is activated in retina-derived cells isolated
from MLC3F-nLacZ mice upon their fusion with myotubes. Primary myogenic
cultures derived from the hindlimb (A, B) or extraocular muscles (C, D) of
MLC3F-nLacZ mouse exhibit MLC3F promoter activity in single cells upon
initiation of differentiation (A, C) and myotubes (B, D) as shown by nuclear β-
gal staining. Co-cultures (day 7) of retinal cells from MLC3F-nLacZ mice and
wild-type primary myoblasts display myotubes containing one to several β-gal+
nuclei (E, F); β-gal signal was never seen in single cells. Primary myoblasts
from MLC3F-nLacZ mice co-cultured with wild-type primary myogenic
cultures fused with the existing host myotubes or formed de novo myotubes
in which all nuclei are β-gal+; single β-gal+ cells (i.e., differentiated myoblasts)
are also present (G, H). Scale bar, 50 μM.
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development.
Fusing retinal cells contribute donor nuclei to host myotubes
The observed eGFP expression by host myotubes could be
due to cytoplasmic contribution of retinal cells or could reflect
nuclear contribution. To gain insight into this aspect, retinal
cells were harvested from eGFP male mice and cultured onto a
day 7 primary myogenic culture isolated from wild-type
female muscles. Fluorescence in situ hybridization (FISH) with
a mouse-specific Y-chromosome probe was then performed
and confirmed the presence of 1–2 male retinal nuclei in host
myotubes containing a total of 10–50 myonuclei (Figs. 2A–
C). Thus, this Y-chromosome analysis indicated that donor
retinal cells fused with the host-derived myotubes, but did
not fuse with each other to form de novo myotubes, as evident
by the absence of myotubes containing only male nuclei.
Notably, the original eGFP signal was drastically reduced and
often fully lost following the processing of the cultures for
FISH analysis. Also, a non-specific general fluorescent back-
ground was generated by the processing. Therefore, we also
correlated eGFP expression in myotubes with the presence of
Y-chromosome by marking areas with eGFP+ myotubes before
processing.
We ruled out the possibility that the fusing retinal cells could
have potentially derived from residual satellite cells originating
from the extraocular muscles (EOM) during the isolation of the
retina. First, microscopy examination did not reveal any
obvious muscle fragments in isolated retinas. Second, there
was no evidence for muscle-specific LacZ reporter expression
in retinas isolated from Myf5nLacZ/+or MLC3F-nLacZ mice, in
contrast to extraocular muscle, which was positive for both
markers (data not shown). Myf5- and MLC3F-driven LacZ
expression identifies satellite cells and myofiber nuclei,
respectively, as previously demonstrated in hindlimb muscles
(Beauchamp et al., 2000; Zammit et al., 2006).
Fusing retinal cells from MLC3F-nLacZ transgenic mice
initiate reporter expression in host myotubes
Following the demonstration that fusing retinal cells
contributed nuclei to myotubes, we asked if such donor nuclei
were induced to express myogenic genes by the myotube
environment. Using the same co-culturing assay system
described above, we demonstrated that fusing retinal cells
from MLC3F-nLacZ mice indeed were able to activate LacZ
expression (Fig. 3). In standard primary myogenic cultures from
hindlimb or EOM muscles of MLC3F-nLacZ mice, expression
of β-gal was observed first in differentiated myoblasts, starting
on day 3, followed by expression in myotubes that were first
seen on day 5 (Figs. 3A–D). In contrast, in the retina–hindlimb
co-cultures, β-gal expression was seen only in myotubes (Figs.
3E, F) and only in 5–10% of myonuclei within a myotube. This
observation indicates direct fusion of donor cells with host
myotubes, rather than de novo myotube formation. Further-
more, the intensity of the β-gal signal in retina–hindlimb co-cultures was far reduced compared to that seen in myotubes
developed in primary myogenic cultures. An overnight β-gal
reaction was required to observe positive nuclei in host
myotubes compared to just a brief development that was
needed for observing β-gal+ nuclei in standard primary cultures
from MLC3F-nLacZ mice. As an additional control, myoblasts
were isolated from hindlimb muscles of MLC3F-nLacZ mice
and co-cultured at a low density (similar to the density of donor
retinal cells) onto a host primary culture. As expected, MLC3F-
nLacZ myoblasts fused with host wild-type myotubes to form
hybrid myotubes with some β-gal+ nuclei and additionally
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β-gal signal (Figs. 3G and H).
We further analyzed the fusion of retinal cells from double
transgenic eGFP/MLC3F-nLacZ mice with host myotubes (Fig.
4). The use of the double transgenic mouse permitted tracking
live cultures for the appearance of eGFP+ myotubes before
fixing the cultures for β-gal detection. In agreement with studies
described in Fig. 1, eGFP+ myotubes first appeared on days 1–2
of co-culture, and their numbers increased thereafter. Co-
cultures fixed on days 3–12 demonstrated β-gal+ nuclei only in
myotubes, while eGFP+ mononucleated cells were always
negative for β-gal. The eGFP signal was reduced after β-gal
staining, especially in β-gal+ myotubes. Therefore, to enhance
the sensitivity of eGFP detection, β-gal stained cultures were
immunolabeled with an anti-GFP antibody. This immunolabel-
ing step showed that not all eGFP+ myotubes contained β-gal+
nuclei (Fig. 4; depicts three representative fields in a day 5 co-
culture). The number of myotubes containing β-gal+ nuclei and
the intensity of β-gal staining gradually increased at later time
points in the co-cultures. For example, in a typical study, the
number of myotubes containing β-gal+ nuclei was 14, 37, and
64 (per well) on co-culture days 5, 9, and 12, respectively.
While the number of β-gal+ nuclei increased in more advanced
co-cultures, the total number of eGFP+ myotubes (detected by
immunostaining) was always much higher than the number of
myotubes with β-gal+ nuclei. Since β-gal is being produced in
the cytoplasmic compartment of the myotube and subsequently
may enter one or more myonuclei (possibly of both donor and
host origin), there may be a need for a critical level of LacZ to be
produced before it can be detected based on enzymatic reaction.
It is also possible that more than one cell type from the retinal
preparations can fuse with host myotubes (resulting in all cases
in eGFP+ myotubes), but only a specific cell type can undergo
myogenic reprogramming. Indeed, the latter possibility has
been confirmed by us as described below based on retinal
preparations from Sca1-GFP mice.Fig. 4. Three representative fields in a co-culture or retina cells from double-transgen
depict co-localization of fusion (GFP+ myotubes) andmyogenic reprogramming (β-ga
hasβ-gal+ nuclei. Arrows point to β-gal+ positive nuclei within the GFP+ myotubes (A
bar, 50 μM.Retinal endothelial cells fuse with myotubes but do not undergo
myogenic reprogramming
To specifically investigate endothelial contribution to
fusion and reprogramming, we analyzed retinal preparations
from Sca1-GFP transgenic mice. Sca1 is a recognized marker
of endothelial cells (van de Rijn et al., 1989). We previously
showed strong GFP expression driven by the Sca1 promoter in
the vasculature of skeletal muscle from Sca1-GFP transgenic
mice (Day et al., 2007). Here we demonstrate that Sca1-GFP
transgene is strongly expressed in the vasculature of the retina
(Fig. 5A). Retinal cells from Sca1-GFP mice contributed GFP
expression to host myotubes when co-cultured with primary
myogenic cells (Figs. 5B–D). The first GFP+ myotubes were
observed on day 1 of co-culture, increasing up to 10–20
myotubes per well by day 3. Single GFP+ cells were also
observed in these co-cultures (Fig. 5B′) and their endothelial
cell identity was confirmed based on immunostaining with an
antibody against CD31 (Figs. 5C–C′″). Additionally, these
retina-derived Sca1-GFP+ cells reacted with anti-Tie2 anti-
body and bound isolectin-B4, recognized endothelial cell
markers (data not shown). Immunostaining with anti-Sca1
antibody confirmed co-localization of the Sca1-GFP transgene
with endogenous Sca1 expression in these GFP+ cells (Fig.
5D). This immunostaining analysis also showed that many of
the host-derived myoblasts in the co-culture also expressed the
Sca1 antigen, but the myotubes were negative for Sca1 (Fig.
5D). After 3–5 days of co-culture, GFP was not detectable any
more in myotubes, indicating that Sca1-driven GFP production
could not be supported by the transcriptional milieu of the
myotubes.
We further assessed the participation of the retinal Sca1+ cell
population in nuclear reprogramming by establishing co-
cultures of retinal cells from double transgenic mice Sca1-
GFP/MLC3F-LacZ and primary myogenic cultures. Myotubes
that were initially positive for GFP no longer expressed GFP byic eGFP/MLC3F-nLacZ mice and wild-type primary myogenic cultures. Panels
l+ nuclei) of retina-derived cells at day 5 of co-culturing; not every GFP+myotube
–A′, B–B′, C–C′) and arrowheads point to GFP+/β-gal−myotubes (A–C). Scale
Fig. 5. GFP+ cells in retinal preparation from Sca1-GFPmice can fuse with host myotubes but do not undergo myogenic reprogramming. (A) Live retina displays Sca1-
GFP transgene expression in the vascular bed, including larger vessels and capillaries. (B–D) GFP+ myotubes (indicated with arrows) are present in co-cultures (day 3)
of retinal cells from Sca1-GFP mice and primary myogenic cultures. Sca1-GFP is expressed only in endothelial compartment of the retinal vasculature in the co-
culture. Arrowheads point to GFP+ endothelial tubes (B and C), which are CD31+ (C and C″). GFP+ images in panels B and C were taken at different exposure times to
depict the relatively lower expression of GFP in myotubes compared to endothelial cells. (D and D′) Endogenous versus transgenic Sca1 expression; images taken with
red, green, and blue filters were merged (D) to show co-localization of endogenous Sca1 expression (red) with Sca1-GFP transgene expression (green) in endothelial
cells (arrowhead); Sca1 antigen is expressed in host monolayer myoblasts, but not in myotubes. (E and F) Outcome of co-culturing sorted GFP+ and GFP− retinal cells
from double transgenic Sca1-GFP/MLC3F-nLacZ with primary myogenic cultures; GFP+ cells fused with myotubes but did not initiate LacZ expression (E), whereas
GFP− cells contributed nuclei to host myotubes that activated MLC3F transgene expression as detected by β-gal staining (F). Scale bar, 50 μM.
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therefore impossible to determine if GFP and β-gal signals co-
localized within myotubes. To circumvent this difficulty, retinal
cells from double transgenic Sca1-GFP/MLC3F-nLacZ mouse
were first sorted by FACS into GFP+ and GFP− populations
(1.5×103 and 1.9×106 events, respectively). Each population
was then separately co-cultured with primary myogenic cells
and analyzed for contribution of lacZ signal in myotubes.
Unexpectedly, β-gal+ myonuclei were detected only in the co-
cultures of Sca1-GFP− retinal cells but not in the Sca1-GFP+
population (Figs. 5E and F), although GFP positive myotubes
were observed in the latter co-culture. These results indicated
that the Sca1-GFP+ (endothelial) cells from the retinal vascular
bed could participate in fusion with myotubes, but the
population of cells capable of myogenic reprogramming
following fusion was not contained within the Sca1-GFP+ cell
fraction. Thus, the capacity to undergo myogenic reprogram-
ming was restricted to a second retina-derived cell type that wasfusing with host myotubes. The study described next aimed to
determine if the second cell type that was able to fuse with
myotubes was contained within the smooth muscle component
of the vasculature.
Retina-derived smooth muscle/pericytes contribute nuclei to
host myotubes
Contractile cells engulfing the endothelium have been
subdivided into smooth muscle and pericytes. The retinal
vascular network consists mainly of microvasculature and the
associated contractile cells have been considered to be pericytes
(Armulik et al., 2005; Klinghoffer et al., 2001). To analyze the
possible presence of pericytes in our retinal preparations and
their possible fusion with host myotubes, we utilized the
XLacZ4 mouse in which the retinal smooth muscle cells and
pericytes were shown to express β-gal in their nuclei (Armulik
et al., 2005; Klinghoffer et al., 2001). Donor retinal cells from
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cultures, fixed at different time points, and reacted with X-Gal
(Fig. 6). Cultures displayed β-gal+ mononucleated cells,
appearing alone or in groups, in each observed arbitrary field
(Figs. 6A and B). Myotubes containing one, and in rare cases
two, β-gal+ nuclei were also identified in the co-cultures (Figs.
6C–E). On average, 15–20 myotubes with β-gal+ nuclei were
found in each well on the initial 2 days of co-culture. β-gal+
nuclei inside myotubes comprised 5–10% of all β-gal+ nuclei
during the initial 2 days. The average number of myotubes
containing β-gal+ nuclei declined to less than 5 per well by day
3. We suggest that this decline in XLacZ4 transgene expression
in myotubes is likely due to the termination of transgene
expression in the myotube environment.
We also analyzed co-cultures of retinal cells derived from
XLacZ4/Sca1-GFP double transgenic mice. This analysis
demonstrated that expression of GFP and β-gal was in
separate cells (Fig. 6F). In view of the aforementioned
observation that Sca1-GFP+ cells fused with myotubes, but
did not contribute to myogenic reprogramming (based on
MLC3F-nLacZ expression), and the finding that retinal cells
derived from XLacZ4 mice fused with myotubes and did not
express Sca1-driven GFP, we propose that the pericytes are in
fact the cells that contribute to reprogramming upon fusion
with myotubes.Fig. 6. Retina-derived XlacZ4 expression in host myotubes. Pericytes/smooth
muscle cells from the retina of Xlacz4 mouse contribute mononucleated cells
(single cells and cell clusters) (A and B) and also fuse with myotubes (C–E)
upon co-culturing of retinal cells with primary myogenic cultures (days 1 and 2
of co-culture). Arrows point to β-gal+ nuclei in myotubes. A co-culture (day 2)
of retinal cells from double transgenic Sca1-GFP/Xlacz4 mice and a primary
myogenic culture display expression of Sca1-GFP and β-gal by separate cells
(F); co-expression of both markers was not found. Scale bar, 100 μm.Circulating cells do not contribute to the pool of retinal cells
that can fuse with host myotubes
We evaluated the possibility that blood borne cells may fuse
with host myotubes. This analysis was important in view of the
published reports implicated circulating and bone marrow-
derived cells in fusion with myotubes (detailed in Introduction)
and the fact that the presence of residual blood cells in retinal
preparations could not be avoided. Nucleated blood cells
obtained from the retro-orbital plexus of double transgenic
eGFP/MLC3F-nLacz or Sca1-GFP mice were co-cultured with
host primary myoblasts in the same manner as the retinal
preparations, applying 105 donor cells per well. Neither GFP+
myotubes nor β-gal+ nuclei were detected. Furthermore, co-
cultures of donor-derived whole bone marrow from double
transgenic eGFP/MLC3F-nLacZ or Sca1-GFP mice (106 cells/
well) and host myogenic cultures developed very rare eGFP+
myotubes (1–2 versus 30–50 in the retina co-cultures), but β-
gal+ nuclei were not detected (data not shown).
Fusing retinal cells initiate MyoD, but not Myf5, gene
expression
In the studies discussed above, myogenic reprogramming of
fusing retinal cells was determined by initiation of MLC3F-
nLacZ expression, an efficient transgenic marker of myogenic
differentiation. During myogenesis of satellite cells, MyoD and
Myf5 are expressed before differentiation and upregulation of
MLC3F-nLacZ transgene (Zammit et al., 2006). Moreover,
MyoD and Myf5 are involved in the induction of the myogenic
lineage during embryogenesis (Ludolph and Konieczny, 1995).
Hence, we were interested to determine if reprogramming of
fusing retinal cells involved expression of the latter two
myogenic regulatory factors.
To investigate possible MyoD expression, we asked if donor
retinal cells from a MyoD-GFP transgenic mouse could activate
transgene expression upon their fusion with host myotubes. In
this mouse, MyoD promoter/enhancer elements drive cytoplas-
mic GFP expression in myofibers. We first established that the
reporter was expressed in myogenic cultures from MyoD-GFP
mice. In both single myofiber cultures and primary myogenic
cultures, all myotubes and some of the mononucleated cells
expressed MyoD-GFP (Figs. 7A–B′; depicted images are of
live cultures). In addition, when cells were cultured at clonal
density, only myogenic clones expressed MyoD-GFP while
transgene expression was absent in non-myogenic clones (not
shown). These observations indicated that MyoD-GFP expres-
sion was specific to the myogenic lineage, permitting us to
utilize this model to investigate myogenic reprogramming of
retinal cells.
Co-cultures of retinal cells from MyoD-GFP mice onto
primary myogenic cultures displayed about 20–50 GFP+
myotubes per well by day 12 of co-culture (Figs. 7C–D′).
MyoD-GFP signal in host myotubes was much weaker than that
seen in myotubes formed in primary myogenic cultures isolated
from MyoD-GFP mice. While some of the MyoD-GFP+
myotubes in the retina–hindlimb co-cultures could be observed
Fig. 8. Fusion with myotubes and myogenic reprogramming of donor retinal
cells from eGFP mouse upon their co-culturing with host chicken primary
myogenic cultures. Rabbit antibody against chicken MyoD detects positive
nuclei of myoblasts and myotubes in primary myogenic cultures from chicken
(A and A′). Mouse retinal cells from eGFP mouse fuse with host chicken
myotubes and some of the fusion events lead to mouse MyoD protein
expression, as detected with an antibody against mouse MyoD, which does not
react with chicken MyoD; GFP+ myotubes appear in early co-cultures and
some of them start expressing mouse MyoD beginning from day 6 of co-culture
(B–B′″). Arrows in parallel fluorescent and phase images point to nuclei
expressing mouse MyoD within one of the GFP+ myotubes. Scale bar, 50 μM.
Fig. 7. MyoD-GFP transgene expression in primary myogenic cultures and in
retina–hindlimb co-cultures. MyoD-GFP is expressed by some mononucleated
cells and by all myotubes in a single myofiber culture (A and A′) and in a
primary myogenic culture from the hindlimb (B and B′). Retinal cells from a
MyoD-GFP mouse, co-cultured onto primary myogenic cultures from hindlimb
muscles activate MyoD-GFP expression upon fusion with myotubes; a day 5
co-cultures is shown (C–D′). Scale bar, 50 μM.
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GFP+ myotubes in the co-cultures were detected only after
immunostaining with anti-GFP antibody. The low-level cyto-
plasmic GFP expression following the fusion of donor retinal
cells from MyoD-GFP mice prevented additional studies on
possible co-expression of MyoD-GFP and MLC3F-nLacZ (or
XLacZ4) in fusing retinal cells from double transgenic mice. To
ensure sufficient donor-based MyoD-GFP signal in host
myotubes, we had to utilize only homozygous MyoD-GFP
mice as the retinal source.
Notably, we detected rare weakly GFP+ mononucleated
cells during enzymatic digestion of retinas of MyoD-GFP
mice and during the initial co-culture days. These GFPlowcells
were negative for MyoD or Pax7, and positive for the
neuronal marker Pax6 (Hitchcock et al., 1996; Klassen et al.,
2004) based on immunostaining. It is possible that some of the
regulatory elements of the MyoD construct are responsive to
the transcriptional milieu in the rare subpopulation of cells thatdisplay such apparently “ectopic” MyoD-GFP expression. To
exclude participation of these MyoD-GFPlow cells in forma-
tion of GFP+ myotubes, freshly isolated retinal cell prepara-
tions from MyoD-GFP mice were sorted into GFP+ (0.009%
of the total sorted events) and GFP− cells and co-cultured with
host myogenic cultures. Only the GFP− cell population
contributed to the development of MyoD-GFP+ myotubes
(data not shown).
The detection of MyoD-GFP reporter expression by host
myotubes following co-culturing with retinal cells suggested
that donor nuclei can initiate MyoD promoter function. We
further demonstrated that fusing retinal cells from mouse could
contribute endogenous mouse MyoD expression in host
myotubes when using chicken muscle for the primary
myogenic cultures and employing mouse-specific antibody
against MyoD (Fig. 8). The appearance of eGFP+ myotubes,
starting on day 1 of co-culture, indicated that retinal cells of
mouse origin fused with the host chicken myotubes. The mouse
monoclonal antibody against rodent MyoD labeled several
adjacent myonuclei only within eGFP+ myotubes, but did not
recognize the host endogenous chicken MyoD (Figs. 8B–B′″).
Fig. 9. Myogenic cultures from MyoD−/− mice support fusion of donor retinal
cells with host myotubes but not myogenic reprogramming. Co-culturing of
retina-derived cells from double transgenic eGFP/MLC3F-nLacZ mice with
myogenic cultures from both wild-type (A–A″, C) and MyoD null mice (B–B″,
D) resulted in fusion of donor cells with host myotubes, monitored by the
development of GFP+ myotubes (A–A″ and B–B″). MyoD+ nuclei were
observed only in wild-type cultures (A–A″), while GFP+ myotubes developed in
MyoD−/− cultures remained negative for MyoD regardless of the age of the co-
culture and number of nuclei in GFP+ myotubes. Likewise, β-gal+ nuclei
(identified by X-Gal reaction) were observed in host myofibers only when
retinal cells were co-cultured with primary myogenic cultures from wild-type
(C), but not fromMyoD−/− (D) mice. Co-cultures were fixed 7 days after adding
the retinal cells. Arrows point to GFP+/MyoD+ (A–A″) or GFP+/MyoD- (B–B″)
myotubes. Scale bar, 33 μM (A–B″), 50 μM (C and D).
459I. Kirillova et al. / Developmental Biology 311 (2007) 449–463In contrast, the rabbit anti-chicken MyoD labeled strongly
nearly all nuclei in chicken myogenic cultures (Figs. 8A and A′).
While the first eGFP+ myotubes were observed after 1 day of
co-culture and their number increased in subsequent days,
nuclei expressing mouse MyoD were first seen by day 6 of co-
culture and were only in some of the eGFP+ myotubes. We
reproducibly detected 3–4 eGFP+ myotubes per well with
several adjacent nuclei positive for mouse MyoD on days 6, 7,
and 9 of co-culturing at the time that the total number of
eGFP+ host chicken myotubes was about 50 per well. The
finding that only some of the eGFP+ myotubes displayed
nuclear expression of mouse MyoD is compatible with the
observed reduced number of host mouse myotubes containing
MLC3F-nLacZ+ nuclei compared to total eGFP+ myotubes in
the co-cultures (Fig. 4).
Notably, we typically detected a higher number of MyoD+
nuclei of mouse origin in host chicken myotubes, or MLC3F-
driven LacZ+ myonuclei in host mouse myotubes (discussed
above), compared to the 1–2 fusing cells identified with the Y-
chromosome probe. This apparent discrepancy in fact indicates
that the myogenic-specific nuclear markers MyoD and MLC3F-
driven LacZ also enter nuclei adjacent to the original donor-
derived nucleus. Furthermore, since MyoD and MLC3F-driven
LacZ are made in the cytoplasmic compartment of the myotube
and subsequently may enter one or more myonuclei (of both
donor and host origin), there might be a need for a critical level
of protein to be produced before it could be detected in host
myotubes. Our observed translocation of donor-contributed
nuclear markers MyoD and nLacZ to host-derived myonuclei is
in accordance with previous observations made with nLacZ-
expressing donor myoblasts, where a higher number of LacZ-
expressing nuclei was detected compared to the true number of
donor cells fused with host myofibers (Yang et al., 1997). Such
translocation of a nuclear protein likely requires strong and
continuous expression of the donor contributed gene product.
Differently, the aforementioned nLacZ expression contributed
by fusing pericytes was eventually shut off in host myotubes
and translocation was not observed.
We also asked if retinal cells from Myf5nLacZ/+ mice could
contribute β-gal+ myofiber nuclei when co-cultured with mouse
primary myogenic cultures. For live distinction of myotubes
with fused retinal cells, we used retinas from Myf5nLacZ/+ mice
that were crossed with eGFP mice. We did not detect any β-gal+
nuclei within myofibers in the co-cultures. The results were
consistent when detection was performed either by immunos-
taining with an antibody against β-gal or by X-Gal reaction. In
contrast, myofiber nuclei of primary myogenic cultures from
Myf5nLacZ/+ mice displayed β-gal label, although the signal was
weaker than in myoblasts and not uniformly maintained in all
myotubes (data not shown; summarized schematically in
Zammit et al., 2006). Myonuclei in some of the myotubes
present in culture day 8 were β-gal+ but such positive
myonuclei were no longer visible on culture day 11. We
suggest that Myf5-driven nLacZ expression is initiated at the
myoblast level and that the host myotube environment may not
be able to promote initiation of Myf5 promoter activity by the
fusing retinal cells.Primary myogenic cultures from mice lacking MyoD support
fusion of donor retinal cells, but do not permit their full
myogenic reprogramming
To gain further insight into the role of the host myotube
transcriptional milieu in supporting myogenic reprogramming,
we investigated if myotubes in primary myogenic culture from
MyoD−/− mice could support fusion and activation of myogenic
promoters in fusing retinal cells. We previously demonstrated
that MyoD−/− myoblasts did not fail to form myotubes but
displayed a longer proliferative period (Yablonka-Reuveni et
al., 1999). Co-cultures of donor retinal cells from eGFP mice
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of GFP in myotubes but no MyoD+ nuclei based on
immunofluorescent analysis. Also, even though MyoD+ nuclei
were not detected, donor retinal cells from MyoD-GFP mice
contributed GFP expression to host myotubes from MyoD−/−
mice (data not shown). Co-cultures of retinal cells from the
double transgenic eGFP/MLC3F-nLacZ mice and MyoD−/−
host myogenic (Fig. 9) or eGFP/Myf5nLacZ/+ mice andMyoD−/−
host myogenic cultures (not shown) also demonstrated eGFP+
myotubes, but no MLC3F-driven or Myf5-driven β-gal protein
expression or MyoD protein in myofiber nuclei or cytoplasm.
Control donor myoblasts from eGFP mice cultured onto host
MyoD−/− primary myogenic cultures started to express MyoD
before fusion and maintained its expression after fusion. In all
studies described here, wild-type primary myogenic cultures
from strain matched (BALB/c) mice or from MyoD+/+ siblings
(generated by crossing MyoD+/- mice) were used as positive
controls for MyoD expression and for supporting MLC3F-
nLacZ expression following fusion of retina-derived cells with
host myotubes. Collectively, these studies suggest that the
transcriptional milieu in MyoD−/− myotubes is sufficient to
activate MyoD reporter expression as seen by MyoD-GFP but
insufficient for activating endogenous MyoD expression or
MLC3F promoter function.
Discussion
Published studies suggest that progenitors other than satellite
cells might be able to contribute to adult myogenesis (Peault et
al., 2007). However, there is a lack of clear consensus about the
origin of these cells, and the extent of their capacity to
contribute to myogenesis in a cell autonomous manner.
Different from satellite cells that perform as myogenic
progenitors both in vivo and in culture, atypical myogenic
cell sources may contribute to myogenesis exclusively after
recruitment by myotubes, as was shown for bone marrow
progenitors (Camargo et al., 2003; Lee et al., 2005) and adult
mesenchymal stem cells (Schulze et al., 2005). However, other
studies claimed the ability of non-satellite cells to assume
myogenic phenotype prior to fusion with the existing myofibers
and in some cases even to occupy the satellite cell niche (Breton
et al., 1995; Dellavalle et al., 2007; Dreyfus et al., 2004;
LaBarge and Blau, 2002; Sampaolesi et al., 2003). There is also
inconsistency between different reports on the potential of non-
myogenic cells to upregulate myogenic genes in host myofibers
(Ferrari et al., 1998; Gussoni et al., 1999; Lapidos et al., 2004;
Wernig et al., 2005). These differences between studies
concerning myogenic outcome might be dependent on the
specific type of donor cells being analyzed, strain background,
and myogenic reprogramming markers being used. Moreover,
atypical myogenic cell sources might function only during
certain types of extensive muscular activities and depletion in
bona fide satellite cells (Deasy et al., 2007; Palermo et al.,
2005), which further complicates their identification in a
reproducible manner.
Here, we investigated the potential of vascular prepara-
tions from juvenile and adult mouse retina to undergo myo-genesis. The choice of retina, an organ richly supplied with
capillary network that is also anatomically separated from
skeletal muscles, ensured that the vasculature preparations
were devoid of satellite cells. Our studies did not detect
spontaneous skeletal myogenesis in cells comprising the
retinal preparation. However, we discovered that certain cells
in the retinal vascular preparations could fuse with develop-
ing myotubes. The fusing retinal cells contributed their
nuclei to the host myotubes, and in some instances these
nuclei underwent myogenic reprogramming, as determined
by the expression of the muscle-specific MLC3F-nLacZ
transgene. This process of myogenic reprogramming
involved the expression of MyoD by the donor retinal cells
as demonstrated by the utilization of MyoD-GFP transgenic
mice and by the detection of mouse MyoD in chicken
myotubes upon co-culturing of mouse retinal cells with
chicken myogenic cultures. However, Myf5 expression, as
judged by Myf5 promoter activity using retinal donor cells
from Myf5nLacZ/+ mice, was not detected in the donor nuclei.
Likewise, we previously reported that the spontaneous
transition of smooth muscle cell lines into skeletal myogen-
esis followed a program where MyoD, but not Myf5,
expression was initiated (Graves and Yablonka-Reuveni,
2000). Using host primary cultures from MyoD null mice,
we also demonstrated that full reprogramming of the fusing
retinal nuclei did not occur in the absence of MyoD
expression in host myotubes. While donor retinal cells fused
with MyoD null myotubes and further initiated MyoD-GFP
transgene expression, neither endogenous MyoD expression
nor activation of the MLC3F-nLacZ transgene by the fused
retinal nuclei was supported. Thus, we identified the muscle-
specific transcription factor MyoD as a key regulator of the
process of myogenic conversion of fusing non-myogenic
cells.
Our findings that MyoD but not Myf5(nLacZ) gene activity
can be detected upon myogenic reprogramming provide new
insight regarding distinctions between the function of Myf5
and MyoD. These two myogenic regulatory factors are
involved in establishing the myogenic lineage during early
development. Genetic ablation of each one of them does not
impair muscle development, suggesting overlapping roles for
Myf5 and MyoD during muscle development (Rudnicki et al.,
1993). Nevertheless, based on our data, it seems that MyoD,
but not Myf5, gene activity participates in the myogenic
reprogramming process. This distinction raises an interesting
frame for investigating the role of myogenic reprogramming in
vivo, as it is possible that such a process would not take place
in MyoD null mice. Furthermore, the availability of Myf5 null
mice that survive to adulthood (Ustanina et al., 2007), offers a
means to investigate the capacity of myotubes lacking Myf5 to
support myogenic reprogramming. Similarly, establishing
whether non-myogenic donor cells from MyoD or Myf5 null
mice would undergo myogenic reprogramming might shed
further light on the role of these myogenic transcription factors
in adult life. The detection of MyoD-expressing cells in non-
muscle tissues (Gerhart et al., 2001; Grounds et al., 1992;
Walker et al., 2001) further raises the possibility that MyoD
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types. The relationship between the latter MyoD-expressing
cells and perictyes/smooth muscle cells warrants further
investigation.
We found more than one population within retinal prepara-
tions capable of fusing with myotubes. Sca1-GFP+ population,
which represented retinal endothelial cells, fused with myotubes
in retina-limb co-cultures but did not activate myogenic genes
(as determined by MLC3F-nLacZ transgene expression) after
fusion. The Sca1-GFP mouse was initially introduced in
connection with transgene expression in adult mouse hemato-
poietic stem cells (Ma et al., 2002). However, our analysis of
blood preparations showed no fusion with host myotubes and
the minimal fusion observed with bone marrow cells was never
followed by myogenic reprogramming. Thus, we were able to
rule out the possible contribution of blood borne and endothelial
cells to nuclear reprogramming upon fusion with myotubes. Our
findings that (a) cells capable of myogenic conversion are
contributed by the Sca1-GFP- population and (b) pericytes
whose nuclei found in myotubes are Sca1-GFP−, suggest that
the cell type undergoing myogenic conversion is contained
within the perictye population. However, available mouse
models did not allow us to analyze more directly the expression
of myogenic markers by fusing pericytes. The MLC3F-nLacZ
mouse, used throughout this study to demonstrate myogenic
reprogramming, could not be used in conjunction with XLacZ4
mouse due to common reporter. Furthermore, MyoD-GFP
mouse could not be used in combination with XlacZ4 due to
very weak GFP expression in heterozygous setting and
differences in expression timing of the reporters in host
myotubes. Nevertheless, the mesenchymal origin and plasticity
of pericytes (i.e., able to give rise to bone and fat cells)
(Farrington-Rock et al., 2004), provide strong support for their
potential reprogramming capacity.
Early heterokaryon studies on the capacity of non-
myogenic cells to undergo myogenic reprogramming involved
forced fusion between non-myogenic and myogenic cells
(Pavlath and Blau, 1986). In the present study, we demon-
strated spontaneous fusion between non-myogenic cells and
host myotubes and subsequent myogenic reprogramming.
While fusion of non-myogenic cells with myotubes might be
a stochastic event that can involve a number of different cell
types, myogenic reprogramming might take place only upon
fusion of specific cell types. Recognizing the difference bet-
ween fusion per se and fusion followed by nuclear
reprogramming may assist in clarifying existing contradictions
about the types of non-satellite cells that can or cannot
contribute to myogenesis.
We acknowledge that studies by others reported on the
capacity of both pericytes and endothelium-related cells to
assume a myogenic fate without fusion with host myotubes
(Dellavalle et al., 2007; Peault et al., 2007). However, within the
experimental models used in the present study, we did not
observe cell autonomous myogenic activity of retina-derived
cells of juvenile and mature mice. It is indeed possible that
amplifying vascular cells in culture by passaging can induce
transition into the skeletal myogenic phenotype, as shown by uspreviously for established smooth muscle lines derived from rat
vasculature (Graves and Yablonka-Reuveni, 2000). Likewise,
pericytes derived from human skeletal muscle underwent
skeletal myogenesis following in vitro expansion (Dellavalle
et al., 2007). Interestingly, in the latter study, skeletal
myogenesis was observed upon fusion of the cultured cells
into multinucleated syncytia, whereas prior to fusion the
mononuclear cells did not express typical markers of myoblasts
(Dellavalle et al., 2007). However, in the present study, we
avoided long-term cell passaging to minimize phenotypic
changes resulting from cell culturing. It is also possible that
vasculature cells isolated from skeletal muscle might be already
triggered in vivo to enter myogenesis due to the cues from the
muscle environment.
Satellite cells were shown to participate in repair of
damaged myofibers (Collins et al., 2005) and their absence
in postnatal life seems to impair postnatal muscle develop-
ment (Kuang et al., 2006). However, it remains unclear if
cells of non-satellite cell origin can participate in myofiber
maintenance during daily routine activities. We determined
that the fusion and myogenic reprogramming ability of the
retina-derived cells and the capacity of the host myotubes to
support these processes were present in juvenile, young
adult, and mature mice (mice up to 1 year of age were
analyzed). Shedding light on alternative cellular origins for
replenishing myofiber nuclei may be beneficial for enhancing
muscle performance during conditions of muscle inactivity
due to injury and disease, which result in muscle atrophy.
Additionally, a capacity to recruit myofiber nuclei from
alternative cells may facilitate reduction of age-linked muscle
atrophy, which seems to correlate with a declining per-
formance of satellite cells with age (Conboy et al., 2005;
Shefer et al., 2006). We conclude with the proposal that
fusion of non-myogenic cells with myofibers, whether or not
followed by myogenic reprogramming, may reflect a
biologically significant process involved in replenishing
myofiber nuclei during skeletal muscle maintenance through-
out the life span.
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